Navigation Links
GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine
Date:6/23/2011

ATLANTA, June 23, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a third site for testing the therapeutic potential of its HIV/AIDS vaccine.  The Los Angeles-based AIDS Research Alliance (ARA) will join with two existing members of GeoVax's clinical trial site team: the AIDS Research Consortium of Atlanta and the Alabama Vaccine Research Clinic at the University of Alabama at Birmingham. The ARA is the nation's only independent, nonprofit HIV/AIDS research institute.

The therapeutic trial is the first trial to test the GeoVax vaccine as a possible treatment for HIV-infected people.  Studies with simian prototypes of the vaccine in infected non-human primates have demonstrated the ability to control viral replication in the absence of anti-viral drugs.  The clinical trial in HIV-infected patients will test safety, vaccine-induced immune responses and the ability of the vaccine to control viral replication.

"We are excited to expand our therapeutic trial team to include the AIDS Research Alliance," said Mark Newman, PhD, Vice President of Research and Development at GeoVax.  "They are a group with a mission that parallels that of GeoVax, developing a vaccine to prevent infection by HIV and developing better treatments for those who become infected."

Dr. Stephen Brown, ARA's medical director, said, "The ARA leadership is very familiar with the GeoVax HIV vaccine products through our involvement with the HVTN, and we are excited to participate in this clinical trial.  The development of new products and approaches that build upon existing antiretroviral drugs regimens would be a major breakthrough."

To be eligible for the study, potential volunteers must have started antiretroviral therapy within 18 months of a negative HIV antibody test and must remain on stable antiretrovira
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Article by GeoVax Labs CSO Featured in The Scientist
2. GeoVax Labs Announces Availability of 2010 Annual Report and Presidents Letter to Stockholders
3. GeoVax Labs, Inc. Announces First Quarter Financial Results
4. GeoVax Labs Reports Fourth Quarter and Year-End 2010 Financial Results
5. GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony
6. GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting
7. GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
8. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
9. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
10. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
11. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015 /PRNewswire/ - bioLytical Laboratories Inc., ... announce its study " Sensitivity of a rapid point ... enhanced by its affinity for HIV gp41 IgM antibodies ... Virology.  This study highlights INSTI,s ability to detect early ... findings at the 8 th annual International AIDS ...
(Date:9/3/2015)... ... September 03, 2015 , ... Park Systems announced that they ... 2015 at 9am PST. The webinar will focus on the methods and materials for ... printing, additive manufacturing is a broad term that encompasses “addition or fusion” of materials ...
(Date:9/2/2015)... HAMILTON, Bermuda , Sept. 2, 2015 Axovant ... on the treatment of dementia, today announced upcoming presentations at ... 4:55 PM at the Baird 2015 Healthcare Conference in ... hotel , Thursday, September 10 at 2:00 PM at ... at the Millennium Broadway Hotel & Conference Center ...
(Date:9/2/2015)... Sep. 02, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. This report briefly ... sequencing technologies, and their applications. Current large and ... developing them. Various applications of sequencing are described ...
Breaking Biology Technology:bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 2bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 3Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 2Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 3Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 4Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2
... fluid boils in tiny "microchannels" has led to formulas ... cool high-power electronics in electric and hybrid cars, aircraft, ... boil in cooling systems dramatically increases how much heat ... to below its boiling point, said Suresh Garimella, the ...
... , , ... OrbusNeich announced today that interim data from a prospective registry showed good ... intervention (PCI) and implantation of the company,s Genous Bio-engineered R stent for ... of 652 consecutive STEMI patients, the rate of major adverse cardiac events ...
... The ... reports issued by the Hawaii Field Office of the National Agricultural Statistics Service (NASS) ... ... industry,s significant contributions to the state,s economy were confirmed by two recent economic reports ...
Cached Biology Technology:New findings could help hybrid, electric cars keep their cool 2New findings could help hybrid, electric cars keep their cool 3New findings could help hybrid, electric cars keep their cool 4OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Safe in a Broad Population of Patients with Primary PCI for STEMI 2OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Safe in a Broad Population of Patients with Primary PCI for STEMI 3Economic Strength of Hawaii Seed Crop Industry Confirmed by Recent Reports 2Economic Strength of Hawaii Seed Crop Industry Confirmed by Recent Reports 3
(Date:8/20/2015)... 2015 The wearable technology market has ... and healthy. However, wearable technology has the potential ... help improve diagnostic capabilities and therapeutic outcomes. Today, ... Wearable Technologies Conference 2015 , where Barrett ... in healthcare.    "Over the past ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas today ... contributor to the Submission Content Management webinar ... a non-profit forum. Dedicated to the Implementation of ... neutral platform for industry, vendors, health authorities, ... and work towards a standard method of ...
(Date:8/12/2015)... Florida , August 12, 2015 ... pace of mobile payment innovation and advanced biometrics technology ... replace the way consumers rely on using their credit ... with reinventing the future for payment services led by ... NXTD ), :  Google, Inc. (NASDAQ: GOOG ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6
... at the University of Gothenburg, Sweden, have developed new ... to identify diagnostic markers more quickly and to personalise ... need for animal trials in clinical studies. Published ... study builds on data analyses of freely available medical ...
... the National Cancer Institute (NCI) late last year to continue ... for The Cancer Genome Atlas (TCGA). Contract awards to Nationwide ... TCGA is a signature program of the National Institutes ... perform cutting-edge genetic testing of tumors from more than 10,000 ...
... an essential nutrientironis scarce, a marine bacterium that launches the ... It recycles iron. By day, it uses iron in ... appears to reuse the same iron in different enzymes to ... watsonii , is one of the few marine microbes that ...
Cached Biology News:New markers for allergic disorders thanks to analysis of medical databases 2Nationwide Children's Hospital awarded $11.5 million contract extension for biospecimen banking 2'Hot-bunking' bacterium recycles iron to boost ocean metabolism 2'Hot-bunking' bacterium recycles iron to boost ocean metabolism 3
Mouse monoclonal antibody to QPCT - glutaminyl-peptide cyclotransferase (glutaminyl cyclase)...
... CLS number is a ... to easily match Cornings ... no availability yet, please ... Sigma-Aldrich number (Z35,347-7) or ...
Request Info...
Designed for use with any of the Agencourt kits in tube format....
Biology Products: